SCHEMBL6207625

SCHEMBL6207625

NC(=O)C(N1CCCCC1)C(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 7/20 0.45
KCNH2 Q12809 7/20 0.45
GAA P10253 1/20 0.44
LMNA P02545 3/20 0.41
TSHR P16473 2/20 0.40
CYP2C19 P33261 5/20 0.40
CYP2D6 P10635 5/20 0.40
CYP1A2 P05177 4/20 0.40
CYP2C9 P11712 3/20 0.40
CYP3A4 P08684 3/20 0.40
CHRM2 P08172 2/20 0.40
HTR1A P08908 2/20 0.40
CHRM1 P11229 2/20 0.40
OPRM1 P35372 2/20 0.40
KCNE1 P15382 1/20 0.40
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 3/20 0.39
HPGD P15428 3/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480997 0.73 KCNA5 (0.73) KCNA5KCNH2GAALMNATSHR
SCHEMBL480998 0.73 KCNA5 (0.73) KCNA5KCNH2GAALMNATSHR
SCHEMBL364905 0.73 KCNA5 (0.50) KCNA5KCNH2LMNACYP2C19CYP2D6
SCHEMBL5541536 0.73 KCNA5 (0.73) KCNA5KCNH2GAALMNATSHR
SCHEMBL12587918 0.73 KCNA5 (0.73) KCNA5KCNH2GAALMNATSHR
SCHEMBL1242086 0.72 KCNA5 (0.43) KCNA5KCNH2GAALMNAKCNE1
SCHEMBL13649151 0.71 KCNA5 (0.73) KCNA5KCNH2GAALMNATSHR
SCHEMBL4418458 0.70 GAA (0.72) KCNA5KCNH2GAALMNATSHR
SCHEMBL3990860 0.70 GAA (0.72) KCNA5KCNH2GAALMNATSHR
SCHEMBL12486937 0.68 LMNA (0.71) KCNA5KCNH2GAALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-A4 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2005-03-30 EP disclosed
EP-1465631-A2 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI Pharmaceuticals, Inc. (US) 2004-10-13 EP disclosed
WO-2003053366-A2 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARMACEUTICALS, INC. (US) 2003-07-03 WO disclosed